(2) Toronto, Ontario--(Newsfile Corp. - January 27, 2021) - In order to protect against the further erosion of shareholder value, a group of shareholders (the "Concerned Shareholders") of FSD Pharma Inc. (the "Company"), including two directors, Anthony Durkacz and Zeeshan Saeed, have called a special meeting of the Company's shareholders to be held on March 31, 2021. As acknowledged by the Company in its January 22, 2021 and January 26, 2021 press releases, on January 4, 2021, shareholders holding more than five percent of the issued shares of the Company carrying the right to vote at a shareholders' meeting requisitioned the Company's directors to call a special meeting of shareholders to be held not later than March 15, 2021. The purpose of the requisitioned meeting is to replace all of the members of the Company's board of directors other than Messrs. Durkacz and Saeed. The additional nominees to the Company's board of directors are Messrs. Larry Latowsky, Fernando Cugliari and Nitin Kaushal, all of whom are well-qualified to serve in this capacity. Additional details about the background and extensive qualifications of these nominees will be provided to shareholders in an information circular prior to the meeting.